Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes, and GPX-003 for the treatment of type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
What is the ticker symbol for Genprex Inc? What does GNPX stand for in stocks?
GNPX is the stock ticker symbol of Genprex Inc. Every public company that trades on a stock exchange gets a ticker symbol.
What is the market capital of Genprex Inc (GNPX)?
As of Fri Nov 22 2024, market cap of Genprex Inc is 9.36 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.
What is the fair value of GNPX stock?
You can check GNPX's fair value in chart for subscribers.
Is Genprex Inc a good stock to buy?
The fair value guage provides a quick view whether GNPX is over valued or under valued. Whether Genprex Inc is cheap or expensive depends on the assumptions which impact Genprex Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for GNPX.